Noss EH, Brenner MB: The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol Rev. 2008, 223: 252-270. 10.1111/j.1600-065X.2008.00648.x.
Article
CAS
PubMed
Google Scholar
Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N: Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol. 2001, 167: 5381-5385.
Article
CAS
PubMed
Google Scholar
Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N: Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum. 2003, 48: 1521-1529. 10.1002/art.11143.
Article
CAS
PubMed
Google Scholar
Garcia-Vicuna R, Gomez-Gaviro MV, Dominguez-Luis MJ, Pec MK, Gonzalez-Alvaro I, Alvaro-Gracia JM, Diaz-Gonzalez F: CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 2004, 50: 3866-3877. 10.1002/art.20615.
Article
CAS
PubMed
Google Scholar
Remmers EF, Lafyatis R, Kumkumian GK, Case JP, Roberts AB, Sporn MB, Wilder RL: Cytokines and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth Factors. 1990, 2: 179-188.
CAS
PubMed
Google Scholar
Barilla ML, Carsons SE: Fibronectin fragments and their role in inflammatory arthritis. Semin Arthritis Rheum. 2000, 29: 252-265. 10.1016/S0049-0172(00)80012-8.
Article
CAS
PubMed
Google Scholar
Sundblad L, Egelius N, Jonsson E: Action of hydrocortisone on the hyaluronic acid of joint fluids in rheumatoid arthritis. Scand J Clin Lab Invest. 1954, 6: 295-302. 10.3109/00365515409134867.
Article
CAS
PubMed
Google Scholar
Jackson JR, Minton JA, Ho ML, Wei N, Winkler JD: Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. J Rheumatol. 1997, 24: 1253-1259.
CAS
PubMed
Google Scholar
Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996, 149: 1607-1615.
PubMed Central
CAS
PubMed
Google Scholar
Linder S: The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 2007, 17: 107-117. 10.1016/j.tcb.2007.01.002.
Article
CAS
PubMed
Google Scholar
Lauzier A, Charbonneau M, Harper K, Jilaveanu-Pelmus M, Dubois CM: Formation of invadopodia-like structures by synovial cells promotes cartilage breakdown in collagen-induced arthritis: involvement of the protein tyrosine kinase Src. Arthritis Rheum. 2011, 63: 1591-1602. 10.1002/art.30305.
Article
CAS
PubMed
Google Scholar
Kim SY: Transglutaminase 2 in inflammation. Front Biosci. 2006, 11: 3026-3035. 10.2741/2030.
Article
CAS
PubMed
Google Scholar
Mehta K, Han A: Tissue transglutaminase (TG2)-induced inflammation in initiation, progression, and pathogenesis of pancreatic cancer. Cancers. 2011, 3: 897-912. 10.3390/cancers3010897.
Article
PubMed Central
CAS
PubMed
Google Scholar
Griffin M, Wilson J: Detection of epsilon(gamma-glutamyl) lysine. Mol Cell Biochem. 1984, 58: 37-49. 10.1007/BF00240603.
Article
CAS
PubMed
Google Scholar
Hasegawa G, Suwa M, Ichikawa Y, Ohtsuka T, Kumagai S, Kikuchi M, Sato Y, Saito Y: A novel function of tissue-type transglutaminase: protein disulphide isomerase. Biochem J. 2003, 373: 793-803. 10.1042/BJ20021084.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mishra S, Murphy LJ: Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem. 2004, 279: 23863-23868. 10.1074/jbc.M311919200.
Article
CAS
PubMed
Google Scholar
Nakaoka H, Perez DM, Baek KJ, Das T, Husain A, Misono K, Im MJ, Graham RM: Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 1994, 264: 1593-1596. 10.1126/science.7911253.
Article
CAS
PubMed
Google Scholar
Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol. 2000, 148: 825-838. 10.1083/jcb.148.4.825.
Article
PubMed Central
CAS
PubMed
Google Scholar
Akimov SS, Belkin AM: Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood. 2001, 98: 1567-1576. 10.1182/blood.V98.5.1567.
Article
CAS
PubMed
Google Scholar
Verderio EA, Telci D, Okoye A, Melino G, Griffin M: A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem. 2003, 278: 42604-42614. 10.1074/jbc.M303303200.
Article
CAS
PubMed
Google Scholar
Ritter SJ, Davies PJ: Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J Biol Chem. 1998, 273: 12798-12806. 10.1074/jbc.273.21.12798.
Article
CAS
PubMed
Google Scholar
Telci D, Collighan RJ, Basaga H, Griffin M: Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide. J Biol Chem. 2009, 284: 29547-29558. 10.1074/jbc.M109.041806.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kuncio GS, Tsyganskaya M, Zhu J, Liu SL, Nagy L, Thomazy V, Davies PJ, Zern MA: TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol. 1998, 274: G240-G245.
CAS
PubMed
Google Scholar
Johnson K, Hashimoto S, Lotz M, Pritzker K, Terkeltaub R: Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol. 2001, 159: 149-163. 10.1016/S0002-9440(10)61682-3.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mehta K, Kumar A, Kim HI: Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem Pharmacol. 2010, 80: 1921-1929. 10.1016/j.bcp.2010.06.029.
Article
CAS
PubMed
Google Scholar
Orlandi A, Oliva F, Taurisano G, Candi E, Di Lascio A, Melino G, Spagnoli LG, Tarantino U: Transglutaminase-2 differently regulates cartilage destruction and osteophyte formation in a surgical model of osteoarthritis. Amino Acids. 2009, 36: 755-763. 10.1007/s00726-008-0129-3.
Article
CAS
PubMed
Google Scholar
Pine PR, Chang B, Schoettler N, Banquerigo ML, Wang S, Lau A, Zhao F, Grossbard EB, Payan DG, Brahn E: Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. Clin Immunol. 2007, 124: 244-257. 10.1016/j.clim.2007.03.543.
Article
CAS
PubMed
Google Scholar
Pham NA, Morrison A, Schwock J, Aviel-Ronen S, Iakovlev V, Tsao MS, Ho J, Hedley DW: Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagn Pathol. 2007, 2: 8-10.1186/1746-1596-2-8.
Article
PubMed Central
PubMed
Google Scholar
Charbonneau M, Harper K, Grondin F, Pelmus M, McDonald PP, Dubois CM: Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. J Biol Chem. 2007, 282: 33714-33724. 10.1074/jbc.M704041200.
Article
CAS
PubMed
Google Scholar
Baldassarre M, Ayala I, Beznoussenko G, Giacchetti G, Machesky LM, Luini A, Buccione R: Actin dynamics at sites of extracellular matrix degradation. Eur J Cell Biol. 2006, 85: 1217-1231. 10.1016/j.ejcb.2006.08.003.
Article
CAS
PubMed
Google Scholar
Kean MJ, Williams KC, Skalski M, Myers D, Burtnik A, Foster D, Coppolino MG: VAMP3, syntaxin-13 and SNAP23 are involved in secretion of matrix metalloproteinases, degradation of the extracellular matrix and cell invasion. J Cell Sci. 2009, 122: 4089-4098. 10.1242/jcs.052761.
Article
CAS
PubMed
Google Scholar
Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J: TGF beta signals through a heteromeric protein kinase receptor complex. Cell. 1992, 71: 1003-1014. 10.1016/0092-8674(92)90395-S.
Article
CAS
PubMed
Google Scholar
Yuan L, Choi K, Khosla C, Zheng X, Higashikubo R, Chicoine MR, Rich KM: Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas. Mol Cancer Ther. 2005, 4: 1293-1302. 10.1158/1535-7163.MCT-04-0328.
Article
CAS
PubMed
Google Scholar
McConoughey SJ, Basso M, Niatsetskaya ZV, Sleiman SF, Smirnova NA, Langley BC, Mahishi L, Cooper AJ, Antonyak MA, Cerione RA, Li B, Starkov A, Chaturvedi RK, Beal MF, Coppola G, Geschwind DH, Ryu H, Xia L, Iismaa SE, Pallos J, Pasternack R, Hils M, Fan J, Raymond LA, Marsh JL, Thompson LM, Ratan RR: Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med. 2010, 2: 349-370. 10.1002/emmm.201000084.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wolf K, Friedl P: Functional imaging of pericellular proteolysis in cancer cell invasion. Biochimie. 2005, 87: 315-320. 10.1016/j.biochi.2004.10.016.
Article
CAS
PubMed
Google Scholar
Summey BT, Graff RD, Lai TS, Greenberg CS, Lee GM: Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res. 2002, 20: 76-82. 10.1016/S0736-0266(01)00064-X.
Article
CAS
PubMed
Google Scholar
Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC: Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 2006, 66: 3034-3043. 10.1158/0008-5472.CAN-05-2177.
Article
CAS
PubMed
Google Scholar
George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM: Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. J Biol Chem. 1990, 265: 11098-11104.
CAS
PubMed
Google Scholar
Pinkas DM, Strop P, Brunger AT, Khosla C: Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol. 2007, 5: e327-10.1371/journal.pbio.0050327.
Article
PubMed Central
PubMed
Google Scholar
Siegel M, Khosla C: Transglutaminase 2 inhibitors and their therapeutic role in disease states. Pharmacol Ther. 2007, 115: 232-245. 10.1016/j.pharmthera.2007.05.003.
Article
PubMed Central
CAS
PubMed
Google Scholar
Verderio E, Gaudry C, Gross S, Smith C, Downes S, Griffin M: Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem. 1999, 47: 1417-1432. 10.1177/002215549904701108.
Article
CAS
PubMed
Google Scholar
Tarantino U, Ferlosio A, Arcuri G, Spagnoli LG, Orlandi A: Transglutaminase 2 as a biomarker of osteoarthritis: an update. Amino Acids. 2011
Google Scholar
Weinberg JB, Pippen AM, Greenberg CS: Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 1991, 34: 996-1005. 10.1002/art.1780340809.
Article
CAS
PubMed
Google Scholar
Stenberg P, Roth B, Wollheim FA: Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease. Eur J Intern Med. 2009, 20: 749-755. 10.1016/j.ejim.2009.08.007.
Article
CAS
PubMed
Google Scholar
Dzhambazov B, Lindh I, Engstrom A, Holmdahl R: Tissue transglutaminase enhances collagen type II-induced arthritis and modifies the immunodominant T-cell epitope CII260-270. Eur J Immunol. 2009, 39: 2412-2423. 10.1002/eji.200939438.
Article
CAS
PubMed
Google Scholar
Bartok B, Firestein GS: Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010, 233: 233-255. 10.1111/j.0105-2896.2009.00859.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Shiozawa S, Yoshihara R, Kuroki Y, Fujita T, Shiozawa K, Imura S: Pathogenic importance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage. Ann Rheum Dis. 1992, 51: 869-873. 10.1136/ard.51.7.869.
Article
PubMed Central
CAS
PubMed
Google Scholar
Yuan L, Siegel M, Choi K, Khosla C, Miller CR, Jackson EN, Piwnica-Worms D, Rich KM: Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene. 2007, 26: 2563-2573. 10.1038/sj.onc.1210048.
Article
CAS
PubMed
Google Scholar
Forsprecher J, Wang Z, Nelea V, Kaartinen MT: Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin. Amino Acids. 2009, 36: 747-753. 10.1007/s00726-008-0125-7.
Article
CAS
PubMed
Google Scholar
Cao L, Shao M, Schilder J, Guise T, Mohammad KS, Matei D: Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene. 2012, 31: 2521-2534. 10.1038/onc.2011.429.
Article
CAS
PubMed
Google Scholar
Ruan Q, Johnson GV: Transglutaminase 2 in neurodegenerative disorders. Front Biosci. 2007, 12: 891-904. 10.2741/2111.
Article
CAS
PubMed
Google Scholar
De Vivo G, Di Lorenzo R, Ricotta M, Gentile V: Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases. Curr Med Chem. 2009, 16: 4767-4773. 10.2174/092986709789909594.
Article
CAS
PubMed
Google Scholar
Huang L, Haylor JL, Fisher M, Hau Z, El Nahas AM, Griffin M, Johnson TS: Do changes in transglutaminase activity alter latent transforming growth factor beta activation in experimental diabetic nephropathy?. Nephrol Dial Transplant. 2010, 25: 3897-3910. 10.1093/ndt/gfq291.
Article
CAS
PubMed
Google Scholar
Kumar A, Xu J, Brady S, Gao H, Yu D, Reuben J, Mehta K: Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells. PLoS One. 2010, 5: e13390-10.1371/journal.pone.0013390.
Article
PubMed Central
PubMed
Google Scholar
Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ: Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration. Am J Pathol. 2008, 173: 631-642. 10.2353/ajpath.2008.080025.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol. 1997, 136: 1151-1163. 10.1083/jcb.136.5.1151.
Article
PubMed Central
CAS
PubMed
Google Scholar
Telci D, Wang Z, Li X, Verderio EA, Humphries MJ, Baccarini M, Basaga H, Griffin M: Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem. 2008, 283: 20937-20947. 10.1074/jbc.M801763200.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mandal S, Johnson KR, Wheelock MJ: TGF-beta induces formation of F-actin cores and matrix degradation in human breast cancer cells via distinct signaling pathways. Exp Cell Res. 2008, 314: 3478-3493. 10.1016/j.yexcr.2008.09.013.
Article
CAS
PubMed
Google Scholar
Buccione R, Caldieri G, Ayala I: Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev. 2009, 28: 137-149. 10.1007/s10555-008-9176-1.
Article
PubMed
Google Scholar
Salliot C, Dougados M, Gossec L: Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials. Ann Rheum Dis. 2009, 68: 25-32.
Article
PubMed Central
CAS
PubMed
Google Scholar
Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM: Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA. 2003, 100: 2047-2052. 10.1073/pnas.0438021100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Wilhelmus MM, van Dam AM, Drukarch B: Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol. 2008, 585: 464-472. 10.1016/j.ejphar.2008.01.059.
Article
CAS
PubMed
Google Scholar
Elli L, Ciulla MM, Busca G, Roncoroni L, Maioli C, Ferrero S, Bardella MT, Bonura A, Paliotti R, Terrani C, Braidotti P: Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease. Lab Invest. 2011, 91: 452-461. 10.1038/labinvest.2010.186.
Article
CAS
PubMed
Google Scholar
Maiuri L, Luciani A, Giardino I, Raia V, Villella VR, D'Apolito M, Pettoello-Mantovani M, Guido S, Ciacci C, Cimmino M, Cexus ON, Londei M, Quaratino S: Tissue transglutaminase activation modulates inflammation in cystic fibrosis via PPARgamma down-regulation. J Immunol. 2008, 180: 7697-7705.
Article
CAS
PubMed
Google Scholar
Oh K, Park HB, Byoun OJ, Shin DM, Jeong EM, Kim YW, Kim YS, Melino G, Kim IG, Lee DS: Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med. 2011, 208: 1707-1719. 10.1084/jem.20101457.
Article
PubMed Central
CAS
PubMed
Google Scholar
Johnson TS, Fisher M, Haylor JL, Hau Z, Skill NJ, Jones R, Saint R, Coutts I, Vickers ME, El Nahas AM, Griffin M: Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J Am Soc Nephrol. 2007, 18: 3078-3088. 10.1681/ASN.2006070690.
Article
CAS
PubMed
Google Scholar
Sohn J, Chae JB, Lee SY, Kim SY, Kim JG: A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor. Korean J Ophthalmol. 2010, 24: 29-34. 10.3341/kjo.2010.24.1.29.
Article
PubMed Central
CAS
PubMed
Google Scholar